4.6 Review

A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications

期刊

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s13346-013-0180-9

关键词

Extracellular vesicles; Exosome; RNAi; miRNA; siRNA; Drug delivery system

资金

  1. Ministry of Education, Culture, Sports, Science and Technology
  2. National Cancer Center Research and Development Fund
  3. Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)
  4. Project for Development of Innovative Research on Cancer Therapeutics
  5. Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)
  6. Council for Science and Technology Policy (CSTP)

向作者/读者索取更多资源

RNA interference (RNAi) is an important avenue for target-specific gene silencing that is mainly performed by either small interfering RNAs (siRNAs) or microRNAs (miRNAs). This novel method is rapidly becoming a powerful tool for gene therapy. However, the rapid degradation of siRNAs and miRNAs and the limited duration of their action in vivo call for an efficient delivery technology. Recently, increasing attention has been paid to the use of extracellular vesicles (EVs) as delivery systems. The use of EVs as small RNA carriers has multiple advantages over conventional delivery systems. In this review, we summarize recent findings regarding the potential application of EVs as small RNA delivery systems. Moreover, we focus on some of the obstacles to EV-based therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据